カート
レポートナンバー 0000039150
VPGMarketResearch
2024 U.S. Hospital Hemostasis Diagnostics Market: Supplier Shares and Sales Segment Forecasts
発刊日 2024/07/01
言語英語
体裁PDF
ライセンス/価格
0000039150
※ご請求は、お申込日のTTSレートで円換算し、消費税を加えた金額になります。 ※本レポートは、英文です。電子媒体での納品となります。 ※本レポートは取り寄せとなりますので、申し込みからお届けまで、多少時間が掛かる場合がございます。
無料サンプル
この新しいレポートはセクションごとに提供されており、特定の情報ニーズと予算に合わせてカスタマイズできます。このレポートでは、以下の内容を含む、アメリカの病院止血診断検査市場の包括的な分析を示しています。
Table of Contents I. Introduction II. Worldwide Market and Technology Overview A. Major Routine and Special Coagulation Tests 1. Introduction 2. Activated Partial Thromboplastin Time (APTT) 3. Alpha-2 Antiplasmin 4. Antithrombin III 5. Bleeding Time 6. D-Dimer 7. Ethanol Flocculation Test 8. Euglobulin Lysis 9. Factor Assays a. Introduction b. Factor II c. Factor V/Factor V Leiden d. Factor VII e. Factor VIII f. Factor IX g. Factor IXa h. Factor X (Stuart Factor) i. Factor Xa j. Factor XI k. Factor XII l. Factor XIII 10. Fibrin Degradation Products 11. Fibrinogen 12. Heparin 13. Hirudin 14. Hypercoagulability and Thrombosis 15. Lipoprotein a 16. Plasmin 17. Plasminogen 18. Plasminogen Activator Inhibitor (PAI) 19. Platelet Function Tests 20. Platelet Aggregation 21. Proteins C and S 22. Prothrombin Fragment 1.2 23. Prothrombin Time (PT) 24. Reptilase Time 25. Thrombin Time 26. Tissue-Type Plasminogen Activator (t-PA) 27. Von Willebrand's Factor B. Instrumentation Review C. Major in Vitro Diagnostic Technologies and Their Potential Applications 1. Chromogenic Substrates 2. Monoclonal and Polyclonal Antibodies 3. Immunoassays 4. Molecular Diagnostics 5. Microcomputers 6. Automation 7. Robotics 8. Artificial Intelligence 9. Dry Chemistry 10. Biosensors III. U.S.A. A. Executive Summary B. Business Environment C. Market Structure D. Market Size, Growth and Major Instrument and Reagent Suppliers’ Sales and Market Shares IV. Major Product Development Opportunities V. Design Criteria For Decentralized Testing Products VI. Alternative Market Penetration Strategies A. Internal Development B. Collaborative Arrangements C. University Contracts D. Distribution Strategies for Decentralized Testing Markets 1. Marketing Approaches 2. Product Complexity 3. Customer Preference 4. Established Suppliers 5. Emerging Suppliers 6. Major Types Of Distributors 7. Market Segmentation VII. Potential Market Entry Barriers and Risks A. Market Maturity B. Cost Containment C. Competition D. Technological Edge and Limitations E. Patent Protection F. Regulatory Constraints G. Decentralized Testing Market Challenges VIII. Competitive Assessments The report provides strategic assessments of over 20 leading coagulation market players and start-up companies with innovative technologies and products, including: Abbott Beckman Coulter/Danaher Becton Dickinson Diagnostica Stago Grifols Helena Laboratories IL/Werfen Roche Sekisui Diagnostics Siemens Healthineers Sysmex Thermo Fisher, and others
List of Tables Major Companies Developing or Marketing Activated Clotting Time Tests Major Companies Developing or Marketing APTT Tests Major Companies Developing or Marketing Alpha-2 Antiplasmin Tests Major Companies Developing or Marketing Antithrombin III Tests Major Companies Developing or Marketing Bleeding Time Tests Major Companies Developing or Marketing D-dimer Tests Major Companies Developing or Marketing Factor Assays Major Companies Developing or Marketing Fibrin Degradation Product Tests Major Companies Developing or Marketing Fibrinogen Tests Major Companies Developing or Marketing Heparin Tests Major Companies Developing or Marketing Plasmin Tests Major Companies Developing or Marketing Plasminogen Tests Major Companies Developing or Marketing Plasminogen Activator Inhibitor Tests Major Companies Developing or Marketing Platelet Aggregation Tests Major Companies Developing or Marketing Protein C Tests Major Companies Developing or Marketing Protein S Tests Major Companies Developing or Marketing PT Tests Major Companies Developing or Marketing Thrombin Time Tests Major Companies Developing or Marketing TPA Tests Major Companies Developing or Marketing Von Willebrand's Factor Tests Executive Summary Table: U.S.A., Hospital Coagulation Diagnostics Market By Product Category U.S.A., Hospital Laboratories Performing Coagulation Tests By Bed Size U.S.A., Hospital Laboratories Average Daily Test Volume U.S.A., Hospital Laboratories Coagulation Test Volume by Assay U.S.A., Major Suppliers of Coagulation Reagents, Estimated Sales and Market Shares U.S.A., Major Suppliers of Coagulation Analyzers, Estimated Sales and Market Shares U.S.A., Coagulation Diagnostics Market By Product Category U.S.A., Major Suppliers of Coagulation Diagnostic Products, Estimated Sales and Market Shares
この商品のレポートナンバー
2024 World Hospital Hemostasis Diagnostics Market: Supplier Shares by Country, Emerging Tests, Technology Trends, Instrumentation Review, Sales Forecasts by Country, and Strategic Profiles of Leading Suppliers
2024/07/01
6,500 USD
Anti-inflammatory Drugs Market -Forecast 2024-2034
2024/08/01
2,150 USD
Bone Growth Stimulators Market Size, Share & Trends Analysis Report, And Segment Forecasts, 2024- 2030
5,950 USD
Global Pharmaceutical Equipment Market 2024-2028
2024/07/25
2,500 USD
Global Artificial Bone Market 2024-2028
2024/07/03